Key result
Electronic cigarette use linked to abnormal cardiovascular biomarkers, though less severe than tobacco cigarettes.
Why the study?
Most premature deaths from tobacco cigarettes are attributable to cardiovascular disease, prompting a review of the overall cardiovascular impact of electronic cigarettes.
Does electronic cigarette use alter cardiovascular risk biomarkers compared to tobacco cigarette smoking?
Does electronic cigarette use alter cardiovascular risk biomarkers compared to tobacco cigarette smoking?
Electronic cigarettes may be a reasonable strategy for smoking cessation if FDA-certified methods fail, but they are not harmless and should not be used by non-smokers due to adverse cardiovascular biomarker profiles.
Answers are grounded in this paper and cite their sources.
Advises against e-cigarette initiation by non-smokers; leaves open net cardiovascular effects versus tobacco cessation.
The majority of premature deaths related to tobacco cigarettes (TCs) are attributable to cardiovascular disease, so it is fitting and timely to review the overall cardiovascular impact of electronic cigarettes (ECs), which have recently exploded onto the tobacco product market. Longitudinal studies of EC users are necessary, but not yet available, to answer the question whether cardiovascular disease is lower in chronic EC users compared to TC smokers, so we must rely on biomarker studies. Several biomarkers that portend increased cardiovascular risk, including markers of increased sympathetic nerve activity, oxidative stress and inflammation, vascular dysfunction, and thrombosis, have been reported to be abnormal after EC use, although often not to the degree found in TC smokers. We conclude that if all FDA-certified strategies for TC smoking cessation have been tried without success, then ECs may be a reasonable strategy for TC smoking cessation, but the message to non-TC smokers must be clear and unwavering: non TC-smokers should not use ECs - they are not harmless.
No takes yet. Share an insight, caveat, or question.
Holly R. Middlekauff (2019) conducted a review in Cardiovascular disease. Electronic cigarettes vs. Tobacco cigarettes was evaluated on Cardiovascular risk biomarkers (sympathetic nerve activity, oxidative stress, inflammation, vascular dysfunction, and thrombosis). Electronic cigarette use is associated with abnormal cardiovascular risk biomarkers, although often not to the degree found in tobacco cigarette smokers, indicating they are not harmless.
Synapse has enriched 10 related papers. Consider them for comparative context: